Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.
Chen X, Tan B, Xing H, Zhao X, Ping Y, Zhang Z, Huang J, Shi X, Zhang N, Lin B, Cao W, Li X, Zhang X, Li L, Jiang Z, Zhang M, Li W, Liu M, Du B, Zhang Y.
Chen X, et al.
Cancer Immunol Immunother. 2024 Jan 17;73(1):13. doi: 10.1007/s00262-023-03586-1.
Cancer Immunol Immunother. 2024.
PMID: 38231412
Free PMC article.